Further investigation into the relationship between serum soluble SLAMF6 concentration and clinical characteristics of RA patients is warranted to better decipher the potential application of SLAMF6 as a clinical biomarker for RA. The gene discussed is SLAMF6; the disease is rheumatoid arthritis.